Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Core Viewpoint - Crescent Biopharma, a clinical-stage biotechnology company, is focused on advancing innovative therapies for cancer patients and will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 [1] Company Overview - Crescent Biopharma aims to become a leading oncology company by developing the next generation of cancer therapies [3] - The company's clinical-stage pipeline includes a PD-1 x VEGF bispecific antibody and novel antibody-drug conjugates (ADCs) [3] - Crescent intends to leverage multiple modalities and established targets to advance transformative therapies for solid tumors, either as single agents or in combination regimens [3] Event Participation - Management is scheduled to participate in a fireside chat on February 12, 2026, at 11:30 a.m. ET [1] - A live webcast of the presentation will be available on the company's website, with a replay accessible for 90 days post-event [2]